The Gamaleya Center warned of the mortal danger of a “live vaccine” Russian news EN
Head of the Gamaleya Center Alexander Gintsburg in an interview with TASS warned of the deadly danger of being used as a “live vaccine”.
The scientist explained that any circulating strain of the strain, including omicron, can become a “live vaccine” if a person has had the disease “on his feet”. However, as it turned out, such a “vaccination” can carry various risks, including fatal ones, as the consequences of a disease of predisposition.
No one can say what the consequences of such a “vaccination” will be, in contrast to the vaccination with Sputnik, the safety of which has long been proven. The reason that complications from live vaccines are different, up to death
Omicron as a “live vaccine”
In early December 2021, when the omicron strain began to spread around the world, the virologist of the Russian Academy of Sciences Petr Chumakov called the omicron strain a live vaccine due to its reduced pathogenicity. People who are infected with the new strain are resistant to disease-causing preferences, he says.
Chumakova agreed with the head of the Department of Infectious Diseases of the South Ural State Medical University (SUSMU) Lyudmila Ratnikova. It is assumed that the coronavirus accumulates its potential, so the omicron strain may become the last mutation of the virus, after which the pandemic will decline. Ratnikova suggested that after the defeat of certain areas of COVID-19, it can develop into a “seasonal” course that will occur with cold symptoms. The researcher believes that the virus will cease to massively cause severe forms of disease, the person himself will cope with it.
Related materials:
Later, the representative of the World Health Organization (WHO) in Russia, Melita Vujnovic, announced that he could become a “live vaccine” against COVID-19 and certainly defeat the pandemic. She noted that such an outcome is possible, but noted that they are talking about it early, since at that time patients with omicron were deficient.
At the same time, WHO Director-General Tedros Adhanom Ghebreyesus stated that the omicron strain is spreading faster than other types of morbidity. The representative of the organization also confirmed that the virus is dangerous, including for those infected and recovering from COVID-19.
In turn, an immunologist, Doctor of Medical Sciences Vladislav Zhemchugov raised his opinion that the properties of the new strain indicate that it can affect various variants of the virus, become a “live vaccine”, so additional restrictive measures should not be introduced. He believes that omicron was the last mutation of COVID-19 before the virus left for another population, as “herd immunity among people has reached such a level that it can no longer reproduce on them.”
It has a powerful score, has a very high level of immunity to all new mutations, and has low lethality, meaning it barely kills healthy people. This needs a review, but wisely
Unlike Zhemchugov, immunologist Nikolai Kryuchkov believes that omicron will not become a “live vaccine”, but several times more citizens suffer from it than from the delta. He went with the fact that the pathogenicity of the new strain and the risk of hospitalization and infection in intensive care decreased. However, with the new strain, its infectivity has increased by about 30 percent, so “omicron is not an easy walk,” Kryuchkov’s emissions. The same opinion is shared by the head of the laboratories of population-variable pathogenic danger of the Gamaleya Center Vladimir Gushchin.
Omicron vaccines
After the discovery of the first data on omicron, the scientific community began to talk about the possibility of adapting to the early development of a vaccine against the future to a new strain, as studies began to show that during a pandemic, the protective effect of vaccination increased, and omicron causes infecting vaccinated people.
In addition, the omicron variant is believed to be resistant to HIV infections. Studies show that the antibodies of recovered people practically do not inhibit the omicron variant. Antibodies after two BioNTech-Pfizer vaccinations also significantly reduced the effectiveness, however, after elimination, the effectiveness was largely restored. Oxford-AstraZeneca and BioNTech-Pfizer heterologous vaccinations are also susceptible to increased protection against the omicron strain.
Related materials:
Moderna began testing vaccines against the omicron strain in early 2022. In this pre-clinical trial of a special vaccine, Moderna recommended fighting a new strain of coronavirus infection using a large amount of vaccination with its drug. Pfizer CEO Albert Burla said a vaccine against the omicron strain would be ready soon in March. He confirmed that the drug will be effective not only against the omicron strain, but also against other detections of coronavirus infection.
As for the Russian Sputnik V, the head of the Gamaleya Center, Alexander Gintsburg, said that the drug does not need to be modified for the omicron strain. Kirill Dmitriev.
Nevertheless, the Gamaleya Center nevertheless began work on updating Sputnik V, a sample of the new version of the vaccine is already ready, and it is possible to replace the existing version of the drug in two and a half to three months.
In that work, Denis Logunov, Deputy Director for the Gamaleya Research Center, said that Russia needs to create a polyvalent vaccine against those in need, depending on several strains of COVID-19, such as delta and other than a micron – determining the number of measurements of the Gamaleya Center. He added that the emergence of omicron disease will lead to an increase in the incidence of coronavirus.
Related materials:
Omicron in Russia
On January 14, Deputy Prime Minister Tatyana Golikova announced that almost 800 cases of micronium infection had been identified in Russia. With this sharp increase in the incidence of a new strain found in Moscow. Golikova explained that the capital regional case is taken as the first strike as a major transport hub.
Denis Logunov, deputy head of the Gamaleya Center, warned that the omicron strain would become a member of the Russian government at the end of January. Epidemiologist, candidate of advanced sciences Alexander Vygonailov admitted that the increase in the incidence of COVID-19 in Russia could reach 100,000 infected per day.
If at the peak in Russia there were 41,000 infections, then at least a six-figure figure is expected here, 100 thousand, and maybe more
On January 16, the WHO representative in Russia, Melita Vujnovic, said that the country was still at the peak of the disease epidemic. She noted that, despite the increase in mortality with omicron, much lower than with the delta strain, one should not be mistaken about those present.
According to the monitoring forecast of the Institute for Health Metrics and Evaluation of the University of Washington Medical School (IHME), the peak incidence of the omicron strain in adults in Russia is January 22. According to their forecast, on February 5 it will be obvious according to official statistics. It is noted that at the peak of the fifth wave of COVID-19, statistics based on tests for coronavirus infection performed could lead to an indicator of 85,700 cells per day.
On January 12, Russian President Vladimir Putin gave his cabinet two weeks to prepare for a new blow to the coronavirus pandemic. He described the epidemiological situation as very difficult. The head of state pays special attention to the fact that the country provides for the supply of food for COVID-19 and conducts a vaccination room.